Registry of Patient With M. Dupuytren and Validation of the Brief MHQ

August 19, 2016 updated by: Daniel Herren, Schulthess Klinik

Buildup of a Registry of Patient With M. Dupuytren and Validation of the Brief Michigan Hand Questionnaire

The purpose of this study is the validation of the Brief Michigan Hand Questionnaire by patient with Morbus Dupuytren and to build up a register.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

examination of the characteristics of Patient with Morbus Dupuytren and the psychometric properties of the Brief Michigan Hand Questionnaire by this patients

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland, 8008
        • Schulthess Klinik

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients with M.Dupuytren with Xiapex injection or surgery

Description

Inclusion Criteria:

  • M.Dupuytren, over 18y, able to speak and understand german

Exclusion Criteria:

  • recurrence, pregnancy, incapable of contracting

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient with M. Dupuytren
Xiaflex Surgery
Xiaflex surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Michigan Hand Questionnaire
Time Frame: 6 weeks
Patient reported outcome measurement by hand disorders
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Joint mobility
Time Frame: 3 years
Measuring the joint mobility of the fingers with the goniometer
3 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain
Time Frame: 3 years
Measuring pain with the Numeric rating scale
3 years
Grip Strength
Time Frame: 3 years
Measuring grip strength with the dynamometer
3 years
Quick DASH
Time Frame: 3 year
Patient reported outcome measurement by arm, shoulder and hand disorders
3 year
Euroqol 5l5d
Time Frame: 3 years
analysis of the costs and utilities
3 years
Michigan Hand Questionnaire
Time Frame: 3 years
Patient reported outcome measurement by hand disorders
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Daniel Herren, Dr. med., Schulthess Klinik

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (ACTUAL)

July 1, 2015

Study Completion (ACTUAL)

July 1, 2015

Study Registration Dates

First Submitted

June 10, 2013

First Submitted That Met QC Criteria

June 10, 2013

First Posted (ESTIMATE)

June 12, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

August 22, 2016

Last Update Submitted That Met QC Criteria

August 19, 2016

Last Verified

August 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dupuytren Contracture

Clinical Trials on Xiaflex surgery

Subscribe